Dexcom Launches World’s First Generative AI Platform for Glucose Monitoring
Dexcom, Inc., a leader in glucose biosensing technology, has launched its proprietary Generative AI platform, becoming the first continuous glucose monitor (CGM) manufacturer to integrate GenAI into its technology.
#HealthcareNews #HealthCareTechnologyNews #HealthcareInnovation #HealthcareTechnology #Ai